Fluticasone propionate/salmeterol 250/50 mcg/INHAL Dry Powder Inhaler, 28 Blisters
RxNorm 896192
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 896192 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fluticasone propionate/salmeterol 250/50 mcg/INHAL Dry Powder Inhaler, 28 Blisters.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
28 ACTUAT fluticasone propionate 0.25 mg/ACTUAT / salmeterol 0.05 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 12331073)
SY
Synonym (SY):
Fluticasone propionate 0.25 mg / salmeterol 0.05 mg per ACTUAT Dry Powder Inhaler, 28 ACTUAT
(Atom ID: 3050713)
SY
Synonym (SY):
Fluticasone propionate 250 mcg / salmeterol 50 mcg (salmeterol xinafoate 72.5 mcg) per ACTUAT Dry Powder Inhaler, 28 ACTUAT
(Atom ID: 5036291)
PSN